Cardiomyopathy, Dilated Clinical Trial
Official title:
A PROSPECTIVE MULTINATIONAL STUDY OF THE NATURAL HISTORY OF PARTICIPANTS WITH BAG3 MUTATION ASSOCIATED DILATED CARDIOMYOPATHY
The purpose of this study is to learn about the natural progression of DCM (dilated cardiomyopathy) caused by BAG3 gene mutations. DCM is a condition as the heart muscle is weakened and the heart becomes enlarged. This makes it hard for the heart to pump enough blood for the body. The study is seeking up to about 35 participants who have: - BAG3 mutation (change in the gene) that causes or is likely to cause dilated cardiomyopathy - NYHA (New York Heart Association) Class I-IV at screening (Stage B-D) - Left Ventricular Ejection Fraction less than or equal to 50% (meaning reduced heart function) All participants in this study will receive their usual treatment. The investigators will observe the natural progression of people who have BAG3 DCM. This will help the investigators better understand the disease and aid in future research. Participants will take part in this study for one year. During this time, participants will visit the site at least 4 times (about every 3 months). Participants will undergo study procedures and give information about their health. These procedures will include a physical exam, cardiac magnetic resonance imaging, echocardiography, ECG monitoring, activity monitoring, cardiopulmonary exercise testing, and blood tests. Participants will answer questions about health and quality of life. The study team will also call participants about 1 time over the phone.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT03560167 -
Early Feasibility Study of the AccuCinch® Ventricular Restoration System in Patients With Prior Mitral Valve Intervention (PMVI) and Recurrent Mitral Regurgitation
|
N/A | |
| Terminated |
NCT00624520 -
Mental Stress Reduction in Defibrillator Patients
|
Phase 3 | |
| Completed |
NCT00549861 -
Characterization of Irreversible Myocardial Injury in Cardiomyopathies by Contrast-enhanced CMR
|
N/A | |
| Terminated |
NCT04222101 -
Association of Insulin Resistance and FGF21 on Cardiac Function in Pediatric Dilated Cardiomyopathy
|
N/A | |
| Not yet recruiting |
NCT02517814 -
Vitamin D Supplementation Can Improve Heart Function in Idiopathic Cardiomyopathy
|
N/A | |
| Completed |
NCT01391507 -
Pilot Study of COR-1 in Heart Failure
|
Phase 2 | |
| Completed |
NCT01940081 -
The Leiden Nonischemic Cardiomyopathy Study
|
||
| Completed |
NCT01181414 -
Spanish Atrial Fibrillation And Resynchronization Study
|
Phase 4 | |
| Not yet recruiting |
NCT06091475 -
Therapy to Maintain Remission in Dilated Cardiomyopathy
|
N/A | |
| Recruiting |
NCT03340675 -
Oral Ifetroban in Subjects With Duchenne Muscular Dystrophy
|
Phase 2 | |
| Not yet recruiting |
NCT06039072 -
Clinical Observation of Long-term Cardiac Function Prognosis in Patients With PPCM Who Have Recovered Cardiac Function
|
||
| Recruiting |
NCT03910725 -
Electrophysiological Phenotyping Of Patients at Risk of Ventricular Arrhythmia and Sudden Cardiac Death
|
||
| Terminated |
NCT01478087 -
Immunoadsorption Therapy for Patients With Non-Ischemic Dilated Cardiomyopathy (DCM)
|
N/A | |
| Recruiting |
NCT00221780 -
Role of Left Ventricular Pacing Site
|
N/A | |
| Terminated |
NCT02958098 -
My Research Legacy Pilot Study
|
||
| Completed |
NCT00123071 -
Variability of Ventricular Mass, Volume, & Ejection Fraction in Pediatric Cardiomyopathy Patients-Pediatric Heart Network
|
N/A | |
| Completed |
NCT00284713 -
Progenitor Cell Therapy in Dilative Cardiomyopathy
|
Phase 1/Phase 2 | |
| Completed |
NCT01260402 -
Randomized Comparison of Endocardial Versus Epicardial - From the Coronary Sinus - Left Ventricular Pacing for Resynchronization in Heart Failure.
|
N/A | |
| Completed |
NCT04192214 -
The Persistence of Autoantibody Neutralisation by BC 007 in Patients With Chronic HFrEF and Autoantibodies Against the Beta1-Adrenergic Receptor
|
Phase 2 | |
| Recruiting |
NCT03040947 -
MRI Sequence and Imaging Protocol Development
|